Showing results (21-30 of 576) with videos related to

Sort By:
Pageof 58
Journal of Pineal Research|March 6, 2018
Exogenous melatonin protects small-for-size liver grafts by promoting monocyte infiltration and releases interleukin-6Zhuolun Song, Bostjan Humar, Anurag Gupta, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2012
Donor information for living donor liver transplantation: where can comprehensive information be found?Emmanuel Melloul, Dimitri Aristotle Raptis, Christian Eugen Oberkofler, et al.
Annals of Surgery|September 2, 2016
Short, Cool, and Well Oxygenated - HOPE for Kidney Transplantation in a Rodent ModelPhilipp Kron, Andrea Schlegel, Olivier de Rougemont, et al.
Nature Reviews. Gastroenterology & Hepatology|July 19, 2020
Modern therapeutic approaches for the treatment of malignant liver tumoursHenrik Petrowsky, Ralph Fritsch, Matthias Guckenberger, et al.
Annals of Surgery|September 2, 2016
Remote Ischemic Preconditioning: A Novel Strategy in Rescuing Older Livers From Ischemia-reperfusion Injury in a Rodent ModelPerparim Limani, Michael Linecker, Christian E Oberkofler, et al.
Annals of Surgery|October 7, 2009
One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac deathOlivier de Rougemont, Stefan Breitenstein, Boris Leskosek, et al.
Annals of Surgery|July 30, 2024
Revolutionizing Liver Transplantation: Transitioning to an Elective Procedure Through Ex Situ Normothermic Machine Perfusion - A Benefit AnalysisZhihao Li, Matthias Pfister, Florian Huwyler, et al.
Annals of Surgery|August 7, 2018
Novel Benefits of Remote Ischemic Preconditioning Through VEGF-dependent Protection From Resection-induced Liver Failure in the MousePatryk Kambakamba, Michael Linecker, Marcel Schneider, et al.
Journal of Hepatology|November 23, 2013
GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acidsDimitri Aristotle Raptis, Perparim Limani, Jae Hwi Jang, et al.
BMC Cancer|October 21, 2016
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trialPerparim Limani, Michael Linecker, Philipp Kron, et al.
Pageof 58